09:40:09 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2025-06-25 Årsstämma 2025
2025-03-05 Bokslutskommuniké 2024
2024-11-27 Kvartalsrapport 2024-Q3
2024-09-25 Kvartalsrapport 2024-Q2
2024-06-27 Ordinarie utdelning SOFTX 0.00 NOK
2024-06-26 Årsstämma 2024
2024-05-29 Kvartalsrapport 2024-Q1
2024-03-27 Extra Bolagsstämma 2024
2024-03-20 Bokslutskommuniké 2023
2023-10-26 Kvartalsrapport 2023-Q3
2023-09-26 Kvartalsrapport 2023-Q2
2023-06-21 Årsstämma 2023
2023-06-21 Kvartalsrapport 2023-Q1
2023-03-30 Ordinarie utdelning SOFTX 0.00 NOK
2023-02-17 Bokslutskommuniké 2022
2022-12-09 Extra Bolagsstämma 2022
2022-10-26 Kvartalsrapport 2022-Q3
2022-08-15 Kvartalsrapport 2022-Q2
2022-04-28 Kvartalsrapport 2022-Q1
2022-04-19 Ordinarie utdelning SOFTX 0.00 NOK
2022-04-17 Årsstämma 2022
2022-02-16 Bokslutskommuniké 2021
2021-12-29 Extra Bolagsstämma 2021
2021-11-17 Kvartalsrapport 2021-Q3
2021-09-08 Kvartalsrapport 2021-Q2
2021-04-29 Kvartalsrapport 2021-Q1
2021-04-14 Ordinarie utdelning SOFTX 0.00 NOK
2021-04-13 Årsstämma 2021
2021-02-09 Bokslutskommuniké 2020
2020-12-14 Kvartalsrapport 2020-Q3
2020-09-30 Kvartalsrapport 2020-Q2
2020-07-01 Ordinarie utdelning SOFTX 0.00 NOK
2020-06-30 Kvartalsrapport 2020-Q1
2020-06-30 Årsstämma 2020
2019-12-20 Extra Bolagsstämma 2019
2019-06-27 Årsstämma 2019
2019-06-03 Ordinarie utdelning SOFTX 0.00 NOK
2018-07-02 Split SOFTX 1:50

Beskrivning

LandNorge
ListaEuronext Growth Oslo
SektorHälsovård
IndustriMedicinteknik
SoftOx Solutions är ett norskt medicintekniskt bolag. Bolaget har utvecklat en egenpatenterad lösning baserad på ättiksyra för behandling av kroniska sår hos patienter. Lösningen används för att eliminera infektioner i samband med biofilmer, vilket består av olika kluster av bakterier. En del av läkemedelsutvecklingen sker i samarbete med övriga forskningsinstitut. SoftOx Solutions etablerades under 2012 och har sitt huvudkontor i Oslo, Norge.
2020-12-21 10:25:20
Our distributor Bonaventura Scandza has signed an agreement with NorgesGruppen
for the sale of SafeDes alcohol-free hand disinfectant.

From February, some of the country's largest grocery chains will start selling
SoftOx SafeDes hand disinfectant under the brand name «Aeris». The agreement
with NorgesGruppen includes Meny, Spar, and Bunnpris stores, where 39 Meny
stores will include the products in a fixed listing, while our partner
Bonaventura Scandza will be allowed to sell our products to all the other stores
locally. Meny has a total of 200 stores, Spar has 295, and Bunnpris has 250.

«I am very pleased with this agreement. This is a large and exciting agreement
for us, as it is aimed specifically at consumers. Here we expect that
considerations of efficacy, safety, and clinically proven skin friendliness will
be of great importance. An important part of the consumer market is children who
are more exposed to skin problems than adults. The product is also nonflammable
and nontoxic," says Sales and Marketing Director Hans Petter Grette of SoftOx
Solutions AS.

As a result of increased focus on infection prevention and control among
consumers, Bonaventura Scandza in collaboration with Aeris AS and SoftOx
Solutions AS has created a new category for infection control products under the
Aeris brand, which includes hand disinfectants from SoftOx Solutions. These
three companies will now together market and sell Aeris's products to the
pharmacies and the retail market in the Nordic countries and the UK.

"We are now experiencing increasing interest in our products. The market demands
effective and skin-friendly disinfectant products, "says Grette

About Bonaventura Scandza: one of Norway's largest distributors of branded
goods to pharmacies, groceries, retail chains, convenience stores, and the
HORECA (hotel, restaurant,catering) market.

About Aeris: Aeris develops medical protective equipment that supports human
safety and protects against infection while focusing on comfort for products
used over time. Aeris promises high quality products at reasonable prices. The
products are sold at several of the largest pharmacy chains in Norway. Aeris is
a wholly-owned Norwegian company with headquarters in Høvik.

About SoftOx Solutions: a Norwegian MedTech company based in Oslo. Based on a
unique and patented technology, the company develops products that will help
combat the emergence of antimicrobial resistance (AMR), biofilm infections in
chronic wounds and viral infections in the respiratory tract. The company's hand
disinfection product is the first product in commercial phase. The company is
listed on the Oslo Stock Exchange Euronext Growth. For more information about
SoftOx, visit www.soft-ox.com